Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Antinuclear Antibodies (ANA) Testing Method Variability: A Survey of Participants in the College of American Pathologists' (CAP) Proficiency Testing Program.

Naides SJ, Genzen JR, Abel G, Bashleben C, Ansari MQ.

J Rheumatol. 2020 Mar 15. pii: jrheum.190933. doi: 10.3899/jrheum.190933. [Epub ahead of print]

PMID:
32173652
2.

Reference intervals for lymphocyte subsets in preterm and term neonates without immune defects.

Amatuni GS, Sciortino S, Currier RJ, Naides SJ, Church JA, Puck JM.

J Allergy Clin Immunol. 2019 Dec;144(6):1674-1683. doi: 10.1016/j.jaci.2019.05.038. Epub 2019 Jun 18.

PMID:
31220471
3.

Preface.

Naides SJ.

Gastroenterol Clin North Am. 2019 Jun;48(2):xi-xiii. doi: 10.1016/j.gtc.2019.03.001. No abstract available.

PMID:
31046980
4.

Newborn Screening for Severe Combined Immunodeficiency and T-cell Lymphopenia in California, 2010-2017.

Amatuni GS, Currier RJ, Church JA, Bishop T, Grimbacher E, Nguyen AA, Agarwal-Hashmi R, Aznar CP, Butte MJ, Cowan MJ, Dorsey MJ, Dvorak CC, Kapoor N, Kohn DB, Markert ML, Moore TB, Naides SJ, Sciortino S, Feuchtbaum L, Koupaei RA, Puck JM.

Pediatrics. 2019 Feb;143(2). pii: e20182300. doi: 10.1542/peds.2018-2300.

5.

Parvovirus B19V Nonstructural Protein NS1 Induces Double-Stranded Deoxyribonucleic Acid Autoantibodies and End-Organ Damage in Nonautoimmune Mice.

Puttaraksa K, Pirttinen H, Karvonen K, Nykky J, Naides SJ, Gilbert L.

J Infect Dis. 2019 Apr 16;219(9):1418-1429. doi: 10.1093/infdis/jiy614.

6.

The role of the laboratory in the expanding field of neuroimmunology: Autoantibodies to neural targets.

Naides SJ.

J Immunol Methods. 2018 Dec;463:1-20. doi: 10.1016/j.jim.2018.04.003. Epub 2018 Oct 6. Review.

PMID:
30300607
7.

Variability in Testing for Antineutrophil Cytoplasmic Antibodies: A Survey of Participants in the College of American Pathologists Proficiency Testing Program.

Karlon WJ, Naides SJ, Crosson JT, Ansari MQ.

Arch Pathol Lab Med. 2016 Jun;140(6):524-8. doi: 10.5858/arpa.2015-0221-CP.

PMID:
27232346
8.

14-3-3η in "Seronegative" Rheumatoid Arthritis.

Naides SJ, Marotta A.

J Rheumatol. 2015 Oct;42(10):1995. doi: 10.3899/jrheum.150330. No abstract available.

PMID:
26429210
9.

Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States.

Kwan A, Abraham RS, Currier R, Brower A, Andruszewski K, Abbott JK, Baker M, Ballow M, Bartoshesky LE, Bonilla FA, Brokopp C, Brooks E, Caggana M, Celestin J, Church JA, Comeau AM, Connelly JA, Cowan MJ, Cunningham-Rundles C, Dasu T, Dave N, De La Morena MT, Duffner U, Fong CT, Forbes L, Freedenberg D, Gelfand EW, Hale JE, Hanson IC, Hay BN, Hu D, Infante A, Johnson D, Kapoor N, Kay DM, Kohn DB, Lee R, Lehman H, Lin Z, Lorey F, Abdel-Mageed A, Manning A, McGhee S, Moore TB, Naides SJ, Notarangelo LD, Orange JS, Pai SY, Porteus M, Rodriguez R, Romberg N, Routes J, Ruehle M, Rubenstein A, Saavedra-Matiz CA, Scott G, Scott PM, Secord E, Seroogy C, Shearer WT, Siegel S, Silvers SK, Stiehm ER, Sugerman RW, Sullivan JL, Tanksley S, Tierce ML 4th, Verbsky J, Vogel B, Walker R, Walkovich K, Walter JE, Wasserman RL, Watson MS, Weinberg GA, Weiner LB, Wood H, Yates AB, Puck JM, Bonagura VR.

JAMA. 2014 Aug 20;312(7):729-38. doi: 10.1001/jama.2014.9132. Erratum in: JAMA. 2014 Nov 26;312(20):2169. Bonagura, Vincent R [Added].

10.

Serum 14-3-3η is a novel marker that complements current serological measurements to enhance detection of patients with rheumatoid arthritis.

Maksymowych WP, Naides SJ, Bykerk V, Siminovitch KA, van Schaardenburg D, Boers M, Landewé R, van der Heijde D, Tak PP, Genovese MC, Weinblatt ME, Keystone EC, Zhukov OS, Abolhosn RW, Popov JM, Britsemmer K, van Kuijk AW, Marotta A.

J Rheumatol. 2014 Nov;41(11):2104-13. doi: 10.3899/jrheum.131446. Epub 2014 Aug 15.

11.

Human parvovirus B19 induced apoptotic bodies contain altered self-antigens that are phagocytosed by antigen presenting cells.

Thammasri K, Rauhamäki S, Wang L, Filippou A, Kivovich V, Marjomäki V, Naides SJ, Gilbert L.

PLoS One. 2013 Jun 12;8(6):e67179. doi: 10.1371/journal.pone.0067179. Print 2013.

12.

Neopterin concentration as an index of disease activity in Crohn's disease and ulcerative colitis.

Husain N, Tokoro K, Popov JM, Naides SJ, Kwasny MJ, Buchman AL.

J Clin Gastroenterol. 2013 Mar;47(3):246-51. doi: 10.1097/MCG.0b013e3182582cdb.

PMID:
23269308
13.
14.

Parvovirus B19 nonstructural protein-induced damage of cellular DNA and resultant apoptosis.

Poole BD, Kivovich V, Gilbert L, Naides SJ.

Int J Med Sci. 2011 Jan 15;8(2):88-96.

15.

Parvovirus B19 genotype specific amino acid substitution in NS1 reduces the protein's cytotoxicity in culture.

Kivovich V, Gilbert L, Vuento M, Naides SJ.

Int J Med Sci. 2010 May 25;7(3):110-9.

16.

Gender differences in the relationship of anti-parvovirus B19 IgG with antinuclear antibody and C-reactive protein in clinical adult serum samples.

O'Bryan TA, Naides SJ.

Rheumatol Int. 2010 Feb;30(4):551-4. doi: 10.1007/s00296-009-1262-3. Epub 2009 Dec 13.

PMID:
20012869
17.

Musculoskeletal complaints and serum autoantibodies associated with chronic hepatitis C and nonalcoholic fatty liver disease.

Banks SE, Riley TR 3rd, Naides SJ.

Dig Dis Sci. 2007 May;52(5):1177-82. Epub 2007 Mar 27.

PMID:
17387612
18.

Ceramide recruits and activates protein kinase C zeta (PKC zeta) within structured membrane microdomains.

Fox TE, Houck KL, O'Neill SM, Nagarajan M, Stover TC, Pomianowski PT, Unal O, Yun JK, Naides SJ, Kester M.

J Biol Chem. 2007 Apr 27;282(17):12450-7. Epub 2007 Feb 17.

19.

Apoptosis of liver-derived cells induced by parvovirus B19 nonstructural protein.

Poole BD, Zhou J, Grote A, Schiffenbauer A, Naides SJ.

J Virol. 2006 Apr;80(8):4114-21.

20.

Human parvovirus B19 infection in children with new onset Type 1 diabetes mellitus.

O'Brayan TA, Beck MJ, Demers LM, Naides SJ.

Diabet Med. 2005 Dec;22(12):1778-9. No abstract available.

PMID:
16401330
21.

Viral arthritis.

Calabrese LH, Naides SJ.

Infect Dis Clin North Am. 2005 Dec;19(4):963-80, x. Review.

PMID:
16297742
22.

Parvovirus B19-induced apoptosis of hepatocytes.

Poole BD, Karetnyi YV, Naides SJ.

J Virol. 2004 Jul;78(14):7775-83.

23.

Glycosphingolipid expression in acute nonlymphocytic leukemia: common expression of shiga toxin and parvovirus B19 receptors on early myeloblasts.

Cooling LL, Zhang DS, Naides SJ, Koerner TA.

Blood. 2003 Jan 15;101(2):711-21. Epub 2002 Sep 5.

PMID:
12393713
24.

Known causes of vasculitis in man.

Naides SJ.

Cleve Clin J Med. 2002;69 Suppl 2:SII15-9. Review. No abstract available.

25.

Induction of an invasive phenotype by human parvovirus B19 in normal human synovial fibroblasts.

Ray NB, Nieva DR, Seftor EA, Khalkhali-Ellis Z, Naides SJ.

Arthritis Rheum. 2001 Jul;44(7):1582-6.

26.

Black tongue.

Ioffreda MD, Gordon CA, Adams DR, Naides SJ, Miller JJ.

Arch Dermatol. 2001 Jul;137(7):968-9. No abstract available.

PMID:
11453829
27.

Infection with Parvovirus B19.

Naides SJ.

Curr Infect Dis Rep. 1999 Aug;1(3):273-278.

PMID:
11095799
28.

Hepatitis E virus infection prevalence among selected populations in Iowa.

Karetnyi YV, Gilchrist MJ, Naides SJ.

J Clin Virol. 1999 Sep;14(1):51-5.

PMID:
10548130
29.

Human parvovirus B19 infection in acute fulminant liver failure.

Karetnyi YV, Beck PR, Markin RS, Langnas AN, Naides SJ.

Arch Virol. 1999;144(9):1713-24.

PMID:
10542021
30.

Rheumatic manifestations of parvovirus B19 infection.

Naides SJ.

Rheum Dis Clin North Am. 1998 May;24(2):375-401. Review.

PMID:
9606764
31.

Human parvovirus B19 infection and hepatitis.

Naides SJ, Karetnyi YV, Cooling LL, Mark RS, Langnas AN.

Lancet. 1996 Jun 1;347(9014):1563-4. No abstract available.

PMID:
8684141
32.

Parvovirus b19 infection associated with acute hepatitis, arthralgias, and rash.

Weinberg JM, Wolfe JT, Frattali AL, Werth VP, Naides SJ, Spiers EM.

J Clin Rheumatol. 1996 Apr;2(2):85-8.

PMID:
19078035
33.

Transient blood plasmacytosis in parvovirus B19 infection: a report of two cases.

Koduri PR, Naides SJ.

Ann Hematol. 1996 Jan;72(1):49-51.

PMID:
8605281
34.

Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia.

Langnas AN, Markin RS, Cattral MS, Naides SJ.

Hepatology. 1995 Dec;22(6):1661-5.

PMID:
7489971
35.

Multiple glycosphingolipids determine the tissue tropism of parvovirus B19.

Cooling LL, Koerner TA, Naides SJ.

J Infect Dis. 1995 Nov;172(5):1198-205.

PMID:
7594654
36.

Aseptic meningitis caused by parvovirus B19.

Koduri PR, Naides SJ.

Clin Infect Dis. 1995 Oct;21(4):1053. No abstract available.

PMID:
8645812
37.

Acute parvovirus B19-induced pancytopenia in the setting of methotrexate therapy for rheumatoid arthritis.

Naides SJ.

Arthritis Rheum. 1995 Jul;38(7):1023. No abstract available.

PMID:
7612034
38.

Viral arthritis including HIV.

Naides SJ.

Curr Opin Rheumatol. 1995 Jul;7(4):337-42. Review.

PMID:
7547112
39.

Absence of parvovirus B19 infection in chronic fatigue syndrome.

Ilaria RL Jr, Komaroff AL, Fagioli LR, Moloney WC, True CA, Naides SJ.

Arthritis Rheum. 1995 May;38(5):638-41.

PMID:
7748220
40.

Infection due to parvovirus B19 in patients infected with human immunodeficiency virus.

Chernak E, Dubin G, Henry D, Naides SJ, Hodinka RL, MacGregor RR, Friedman HM.

Clin Infect Dis. 1995 Jan;20(1):170-3.

PMID:
7727646
41.

Viral infection including HIV and AIDS.

Naides SJ.

Curr Opin Rheumatol. 1994 Jul;6(4):423-8. Review.

PMID:
8068514
42.

Established fibromyalgia syndrome and parvovirus B19 infection.

Berg AM, Naides SJ, Simms RW.

J Rheumatol. 1993 Nov;20(11):1941-3.

PMID:
8308782
43.

Parvovirus B19 infection in human immunodeficiency virus type 1-infected persons failing or intolerant to zidovudine therapy.

Naides SJ, Howard EJ, Swack NS, True CA, Stapleton JT.

J Infect Dis. 1993 Jul;168(1):101-5.

PMID:
8515096
44.

Viral infection including HIV and AIDS.

Naides SJ.

Curr Opin Rheumatol. 1993 Jul;5(4):468-74. Review.

PMID:
8395196
45.

Parvovirus B19 infection.

Naides SJ.

Rheum Dis Clin North Am. 1993 May;19(2):457-75. Review.

PMID:
8502782
46.

Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistence.

Foto F, Saag KG, Scharosch LL, Howard EJ, Naides SJ.

J Infect Dis. 1993 Mar;167(3):744-8.

PMID:
8440942
47.

Parvovirus B19 infection causing pure red cell aplasia in a recipient of pediatric donor kidneys.

Corral DA, Darras FS, Jensen CW, Hakala TR, Naides SJ, Krause JR, Starzl TE, Jordan ML.

Transplantation. 1993 Feb;55(2):427-30. No abstract available.

48.

Diagnosis of fetal infection in the patient with an ultrasonographically detected abnormality but a negative clinical history.

Weiner CP, Grose CF, Naides SJ.

Am J Obstet Gynecol. 1993 Jan;168(1 Pt 1):6-11. Review.

PMID:
8420349
49.

Subcutaneous pancreatic fat necrosis associated with acute arthritis.

Saag KG, Niemann TH, Warner CA, Naides SJ.

J Rheumatol. 1992 Apr;19(4):630-2.

PMID:
1593588
50.

A combined pseudoreplica-immunochemical technique for research and diagnostic virology.

Fritz B, Moore K, Naides SJ.

Microsc Res Tech. 1992 Mar 1;21(1):59-64.

PMID:
1375519

Supplemental Content

Loading ...
Support Center